The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 9,500 members worldwide.
In order to help Chinese pharmaceutical companies update the newest technology of risk control and validation during the process, PDA held its annual trainings in Beijing and Shanghai. The themes are “Quality Risk Management for Aseptic Processes” and “Process Validation: A Lifecycle Approach” .
During the four days training in Beijing, 24 to 25 October, and Shanghai, 28 to 29 October. More than 120 professionals from 65 pharmaceutical companies attended the 4 days courses. Hal Baseman, the Principal of Valsource, and the Member of PDA Council who is the lecturer of the course “Quality Risk Management for Aseptic Processes”, shared his abundant experience of pharmaceutical industry and rich knowledge. Robert L. Dana, the Senior Vice President of PDA, who owned 40 years pharmaceutical industry experiences present his thorough understandings to the theme of “Process Validation: A Lifecycle Approach” .
“These courses are very inspiring, some of the validation approaches are very useful and practical for my daily works.” One of the attendees said, who are the QC Supervisor of a pharmaceutical company. Tofflon as the exclusive sponsor of this activities, shared its experience with the attendees regard of “freeze drying system in practice ” at the night of 24th , “Your course is very practical, you solved lots of problems we meet in the daily work”, one attendees commented. Chen Zhi ,who is the technical manager from Tofflon System&Solution Department, answered the attendees’ questions.